Literature DB >> 9816225

Clonal analysis of bilateral breast cancer.

A Shibata1, Y C Tsai, M F Press, B E Henderson, P A Jones, R K Ross.   

Abstract

Forty-nine pairs of bilateral breast tumors (41 synchronous and 8 asynchronous cases) were examined for X-chromosome inactivation status and p53 mutations to address the issue of their clonality. Among 12 cases that were informative for the trinucleotide repeat polymorphism in exon 1 of the androgen receptor gene on the X chromosome, 3 cases were found to have different alleles of the locus inactivated in the right and left breast tumors, indicating that the two tumors arose from distinct transformed cells. Thirteen tumors (13%) from 11 women (22%) contained somatic mutations in exons 5-8 of the p53 gene. In two cases, both breast tumors harbored p53 mutations, but the specific mutations were not identical. Seven synchronous and two asynchronous cases had p53 mutations in one tumor only. A germ line p53 mutation at codon 248, one of the most common p53 mutations in Li-Fraumeni syndrome, was observed in one case. Immunohistochemical analysis of p53 protein with a monoclonal antihuman p53 antibody showed concordant positivity between the right and left tumors in three bilateral breast cancer cases. Our results suggest that at least some bilateral breast tumors originate from distinct cells, but that some bilateral breast tumors may be related through a common p53 abnormality.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9816225

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  16 in total

Review 1.  The clonal origin and clonal evolution of epithelial tumours.

Authors:  S B Garcia; M Novelli; N A Wright
Journal:  Int J Exp Pathol       Date:  2000-04       Impact factor: 1.925

2.  Comprehensive Genomic Profiling Aids in Distinguishing Metastatic Recurrence from Second Primary Cancers.

Authors:  Benjamin A Weinberg; Kyle Gowen; Thomas K Lee; Sai-Hong Ignatius Ou; Robert Bristow; Lauren Krill; M Isabel Almira-Suarez; Siraj M Ali; Vincent A Miller; Stephen V Liu; Samuel J Klempner
Journal:  Oncologist       Date:  2017-02-13

Review 3.  Intratumoral Heterogeneity in Ductal Carcinoma In Situ: Chaos and Consequence.

Authors:  Vidya C Sinha; Helen Piwnica-Worms
Journal:  J Mammary Gland Biol Neoplasia       Date:  2018-09-07       Impact factor: 2.673

4.  Disease evolution and heterogeneity in bilateral breast cancer.

Authors:  Elena Fountzilas; Vassiliki Kotoula; Flora Zagouri; Eleni Giannoulatou; George Kouvatseas; George Pentheroudakis; Triantafyllia Koletsa; Mattheos Bobos; Kyriaki Papadopoulou; Epaminontas Samantas; Efterpi Demiri; Spyros Miliaras; Christos Christodoulou; Sofia Chrisafi; Evangelia Razis; Florentia Fostira; Dimitrios Pectasides; George Zografos; George Fountzilas
Journal:  Am J Cancer Res       Date:  2016-11-01       Impact factor: 6.166

5.  Molecular cytogenetic investigations of synchronous bilateral breast cancer.

Authors:  K Agelopoulos; N Tidow; E Korsching; R Voss; B Hinrichs; B Brandt; W Boecker; H Buerger
Journal:  J Clin Pathol       Date:  2003-09       Impact factor: 3.411

6.  Evidence for multiclonality in multicentric Kaposi's sarcoma.

Authors:  P S Gill; Y C Tsai; A P Rao; C H Spruck; T Zheng; W A Harrington; T Cheung; B Nathwani; P A Jones
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-07       Impact factor: 11.205

7.  Oncotype DX in Bilateral Synchronous Primary Invasive Breast Cancer.

Authors:  Maria Karsten; Michelle Stempel; Julia Radosa; Sujata Patil; Tari A King
Journal:  Ann Surg Oncol       Date:  2015-09-04       Impact factor: 5.344

8.  Genomic alterations in sporadic synchronous primary breast cancer using array and metaphase comparative genomic hybridization.

Authors:  Arezou A Ghazani; Nona Arneson; Keisha Warren; Melania Pintilie; Jane Bayani; Jeremy A Squire; Susan J Done
Journal:  Neoplasia       Date:  2007-06       Impact factor: 5.715

9.  Prediction of outcome after diagnosis of metachronous contralateral breast cancer.

Authors:  Sara Alkner; Pär-Ola Bendahl; Mårten Fernö; Jonas Manjer; Lisa Rydén
Journal:  BMC Cancer       Date:  2011-03-30       Impact factor: 4.430

10.  Are ipsilateral breast tumour invasive recurrences in young (< or =40 years) women more aggressive than their primary tumours?

Authors:  B Sigal-Zafrani; M A Bollet; G Antoni; A Savignoni; A Vincent-Salomon; J-Y Pierga; R Salmon; X Sastre-Garau; A Fourquet
Journal:  Br J Cancer       Date:  2007-09-18       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.